|
| 37347242 | ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 34906521 | Response to McGurk et al. | Genet Med | 2022 |
| 35616647 | Clinical validity assessment of genes frequently tested on intellectual disability/autism sequencing panels. | Genet Med | 2022 |
| 35802134 | ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2022 |
| 36044908 | Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission Risk. | Annu Rev Genomics Hum Genet | 2022 |
| 33381861 | Growth, development, and phenotypic spectrum of individuals with deletions of 2q33.1 involving SATB2. | Clin Genet | 2021 |
| 33578785 | Clinical Syndromic Phenotypes and the Potential Role of Genetics in Pulmonary Vein Stenosis. | Children (Basel) | 2021 |
| 34131312 | Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34345026 | Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34012069 | Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34012068 | ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 32252413 | Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. | Genes (Basel) | 2020 |
| 32728138 | Correction: Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. | Genet Med | 2020 |
| 32359473 | Insufficient Evidence for "Autism-Specific" Genes. | Am J Hum Genet | 2020 |
| 32203227 | Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability. | Genet Med | 2020 |
| 30275510 | Correction: Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation. | Genet Med | 2019 |
| 32642732 | Genetics of human malignant peripheral nerve sheath tumors. | Neurooncol Adv | 2019 |
| 30190611 | Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation. | Genet Med | 2019 |
| 31182824 | Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. | Genet Med | 2019 |
| 31010905 | Health Supervision for Children With Neurofibromatosis Type 1. | Pediatrics | 2019 |
| 30971833 | Response to Knoppers et al. | Genet Med | 2019 |
| 29290338 | Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848. | Am J Hum Genet | 2018 |
| 29915380 | Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2018 |
| 29261174 | School liaison program supporting children with neurofibromatosis type 1: a model of care for children with chronic disease. | Genet Med | 2018 |
| 27756070 | Long-Gap Esophageal Atresia Is a Unique Entity within the Esophageal Atresia Defect Spectrum. | Neonatology | 2017 |
| 28406491 | Response to Biesecker. | Genet Med | 2017 |
| 27854360 | Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. | Genet Med | 2017 |
| 26731259 | A Case of HDR Syndrome and Ichthyosis: Dual Diagnosis by Whole-Genome Sequencing of Novel Mutations in GATA3 and STS Genes. | J Clin Endocrinol Metab | 2016 |
| 27522563 | Commentary: 2016 Clinical Epilepsia Prize. | Epilepsia | 2016 |
| 27282546 | BRAT1 mutations present with a spectrum of clinical severity. | Am J Med Genet A | 2016 |
| 27400896 | Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome. | Circulation | 2016 |
| 27126233 | A Clinician's perspective on clinical exome sequencing. | Hum Genet | 2016 |
| 26861553 | Classifying Germline Sequence Variants in the Era of Next-Generation Sequencing. | Clin Chem | 2016 |
| 26178529 | GenomeConnect: matchmaking between patients, clinical laboratories, and researchers to improve genomic knowledge. | Hum Mutat | 2015 |
| 23347240 | Chromosomal microarray impacts clinical management. | Clin Genet | 2014 |
| 30345165 | Advances in Genetic Discovery and Implications for Counseling of Patients and Families with Autism Spectrum Disorders. | Curr Genet Med Rep | 2014 |
| 25516202 | Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield. | BMC Genomics | 2014 |
| 24811917 | Copy number variation plays an important role in clinical epilepsy. | Ann Neurol | 2014 |
| 24491508 | Treating the whole person with autism: the proceedings of the Autism Speaks National Autism Conference. | Curr Probl Pediatr Adolesc Health Care | 2014 |
| 23239472 | Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations. | Am J Med Genet A | 2013 |
| 23897869 | Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment. | Neurology | 2013 |
| 23558256 | Density matters: comparison of array platforms for detection of copy-number variation and copy-neutral abnormalities. | Genet Med | 2013 |
| 21779791 | The adult galactosemic phenotype. | J Inherit Metab Dis | 2012 |
| 23326855 | Whole-genome sequencing: ready for prime time? | Clin Chem | 2012 |
| 23012407 | Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. | Proc Natl Acad Sci U S A | 2012 |
| 22752073 | A prospective study of radiographic manifestations in Hutchinson-Gilford progeria syndrome. | Pediatr Radiol | 2012 |
| 22786613 | Oligonucleotide microarrays for clinical diagnosis of copy number variation and zygosity status. | Curr Protoc Hum Genet | 2012 |
| 22422049 | Exploring concordance and discordance for return of incidental findings from clinical sequencing. | Genet Med | 2012 |
| 22331816 | Phenotypic information in genomic variant databases enhances clinical care and research: the International Standards for Cytogenomic Arrays Consortium experience. | Hum Mutat | 2012 |
| 22083160 | Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome. | Hypertension | 2012 |